Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Invicro, now part of Fortrea, is a premier global provider of quantitative imaging biomarkers, comprehensive core lab services, advanced data analytics, and innovative software solutions. Catering to pharmaceutical and biotechnology companies, Invicro supports drug discovery and development pipelines from preclinical research through to late-phase clinical trials. Their expertise spans multiple therapeutic areas, including oncology, neuroscience, and metabolic diseases, aiming to accelerate the delivery of new therapies to patients by providing actionable insights through advanced imaging and analysis.
Serves as the central hub for corporate leadership, strategic operations, research and development initiatives, and client engagement for Invicro's global activities.
Located in Boston's Seaport District, known for its modern infrastructure and proximity to leading research institutions and biotech companies. The facility likely includes advanced imaging analysis labs and collaborative workspaces.
A dynamic and innovative environment focused on scientific excellence, collaboration, and problem-solving to advance medical research. As part of Fortrea, it emphasizes a patient-centric approach and high-quality service delivery.
The Boston headquarters is pivotal for Invicro's operations, connecting its global network of labs and offices, and driving its mission to accelerate drug development through advanced imaging science.
Invicro supports pharmaceutical and biotech clients globally with a network of laboratories and offices across North America, Europe, Asia, and Australia. Its functions include preclinical and clinical imaging studies, radiopharmaceutical services, advanced data analytics, software deployment, and scientific consultation, facilitating multicenter international drug development programs.
27 Drydock Avenue, 6th Floor
Boston
MA
USA
Address: 3971 S. Research Park Drive, Ann Arbor, MI 48108, USA
Provides regional access to Invicro's comprehensive preclinical imaging capabilities and expertise, supporting biotech and pharma in the Midwest US and beyond.
Address: One Science Park, New Haven, CT 06511, USA
Serves the dense Northeast US biotech cluster, offering specialized radiopharmaceutical development, imaging, and analytical services.
Address: Burlington Danes Building, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK
Key European operational site, managing clinical trials, supporting EU-based clients, and driving research collaborations in neuroscience and oncology.
Address: Arvid Wallgrens Backe 20, Medicinareberget, 413 46 Göteborg, Sweden
Serves as a center of excellence for neuroscience imaging and radiochemistry in Northern Europe, supporting global projects requiring these specialized capabilities.
Address: Room 501, Building 10, Lane 289, Bisheng Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai 201204, China
Supports the growing pharmaceutical development market in China and the broader APAC region, facilitating local and global clinical studies with regional expertise.
Address: Invicro at Herston Imaging Research Facility (HIRF), Building 30, Royal Brisbane & Women's Hospital Campus, Cnr Gilchrist Ave & Herston Rd, Herston QLD 4006, Australia
Serves the Australian and New Zealand biotech and pharmaceutical sectors, supporting early to late-phase clinical development with cutting-edge imaging capabilities.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Invicro' leadership includes:
Invicro has been backed by several prominent investors over the years, including:
The most significant executive-level change in the past 12 months has been Invicro's integration into Fortrea, following Fortrea's acquisition of REALM IDx (Invicro's former parent company) in February 2024. This positions Invicro under new parent company leadership. Specific Invicro-level executive hires or departures announced publicly, separate from this strategic integration, have not been prominent. The leadership team listed on the Invicro website appears to continue leading the business unit within Fortrea.
Discover the tools Invicro uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Invicro commonly utilizes the [first_initial][last]@invicro.com email format (e.g., jdoe@invicro.com). This pattern is a widely adopted standard for professional communication within the company.
[first_initial][last]@invicro.com
Format
msilva@invicro.com
Example
90%
Success rate
Fortrea • February 1, 2024
Fortrea announced the completion of its acquisition of REALM IDx, Inc., including its subsidiaries Invicro and Ambry Genetics. This acquisition enhances Fortrea's capabilities in advanced clinical diagnostics and imaging, integrating Invicro's specialized biomarker and core lab services....more
Invicro Press Release • November 8, 2023
Invicro announced the expansion of its advanced pathology services to include multiplex immunofluorescence (mIF), enhancing its support for complex immuno-oncology clinical trials by enabling deeper spatial and cellular analysis of the tumor microenvironment....more
Invicro Press Release • October 17, 2023
Invicro introduced VivoPrecon_AI™, an AI-powered software platform designed to automate and standardize preclinical tumor volume measurements from imaging data, aiming to improve efficiency and consistency in oncology drug discovery....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Invicro, are just a search away.